Notes

1. Live attenuated vaccines that are contraindicated in some medical conditions
2. Recommended pneumococcal vaccination dosing schedule:

• • Vaccine naïve individuals/unknown vaccination status: 1 dose of PCV20 (standalone)* OR 1 dose of PCV15/PCV13 followed by 1 dose of PPSV23 (at ≥1 year apart, unless immunocompromised group – at 8 weeks apart).
  • Previously received:
    
    1. PCV13 only: 1 dose of PCV20 (at ≥1 year after the PCV13 dose) OR 1 dose of PPSV23 (at ≥1 year after the PCV13 dose).
    2. Only PPSV23: 1 dose of PCV20/PCV15/PCV13 (at ≥1 year after the last PPSV23 dose).
    3. PCV13 & 1 dose of PPSV23: 1 dose of PCV20 (at ≥5 years after the last PPSV23 dose).
    4. 1 dose of PCV20: no additional vaccine dose recommended.

• • • Previously received both PCV13 & PPSV23, AND PPSV23 was received at age ≥65 years or older: Based on shared clinical decision-making, 1 dose of PCV20 (at ≥5 years after the last pneumococcal vaccine dose).
    • Previously received both PCV13 & PPSV23, both were received before the age of 65 years: 1 dose of PCV20 (at ≥5 years after last PPSV23 dose).

3. Only bivalent recombinant RSVpreF vaccine is indicated for pregnant women.

4. 2 doses of latest COVID-19 vaccine (at ≥6 months apart).

*preferred option